Accelerating the Translation of Genomic Insight to Therapeutics
Last month, Genuity Science announced a multiyear collaboration with Ionis Pharmaceuticals aimed at accelerating this transition from target to therapeutic in multiple disease areas. GEN caught up with Leo Sahelijo, MD, vp of translational medicine at Ionis, and Jeffrey Gulcher, MD, PhD, chief scientific officer at Genuity to discuss the collaboration.
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.
